Amdocs (NASDAQ:DOX) Updates FY 2025 Earnings Guidance

Amdocs (NASDAQ:DOX) updated its FY 2025 earnings guidance on Tuesday. The company provided EPS guidance of 6.859-7.116 for the period, compared to the consensus EPS estimate of 6.970. The company issued revenue guidance of $4.4 billion-$4.6 billion, compared to the consensus revenue estimate of $4.5 billion. Amdocs also updated its Q2 2025 guidance to 1.670-1.730 EPS.

Amdocs Trading Down 1.8 %

Shares of Amdocs stock traded down $1.58 during trading on Wednesday, reaching $85.28. The company’s stock had a trading volume of 131,770 shares, compared to its average volume of 550,295. The company has a quick ratio of 1.20, a current ratio of 1.20 and a debt-to-equity ratio of 0.21. Amdocs has a 52-week low of $74.41 and a 52-week high of $94.04. The company has a market cap of $9.63 billion, a price-to-earnings ratio of 20.11, a PEG ratio of 1.47 and a beta of 0.71. The firm’s 50-day moving average is $85.96 and its two-hundred day moving average is $86.40.

Amdocs (NASDAQ:DOX) last issued its quarterly earnings results on Tuesday, February 4th. The technology company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.64 by ($0.19). Amdocs had a return on equity of 18.69% and a net margin of 9.85%. On average, sell-side analysts anticipate that Amdocs will post 6.19 earnings per share for the current year.

Amdocs Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st were issued a dividend of $0.479 per share. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.25%. The ex-dividend date was Tuesday, December 31st. Amdocs’s payout ratio is presently 45.28%.

Analysts Set New Price Targets

A number of equities research analysts have commented on the stock. StockNews.com cut shares of Amdocs from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, January 14th. Oppenheimer raised their target price on shares of Amdocs from $98.00 to $105.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 13th. Finally, Barclays decreased their target price on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating on the stock in a research note on Thursday, November 14th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, Amdocs presently has a consensus rating of “Moderate Buy” and an average price target of $101.20.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.